Patents by Inventor Vincent Ronfard
Vincent Ronfard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938173Abstract: Provided are methods for repairing a wound or inducing the proliferative phase of a wound comprising administering a composition comprising a protease mixture comprising collagenases and a neutral protease to the wound in an amount effective for repair of wound tissue or for inducing the proliferative phase in the wound.Type: GrantFiled: December 10, 2015Date of Patent: March 26, 2024Assignee: SMITH & NEPHEW, INC.Inventors: Ira Herman, Vincent Ronfard, Lei Shi
-
Publication number: 20240026291Abstract: The invention relates to a device (1) for preparing a cell suspension comprising an enzyme reservoir (10), a first purification compartment (20) for receiving a first purification material (P1), wherein the first purification compartment (20) is in fluid connection or can be brought into fluid connection with the enzyme reservoir (10), a syringe (40) comprising a barrel (41) defining a barrel compartment (45) and a piston (42) which is movably arranged in the barrel compartment (45), wherein the syringe (40) comprises a syringe inlet (43) connected to the barrel compartment (45), wherein the syringe inlet (43) is in fluid connection or can be brought into fluid connection with the first purification compartment (20), and wherein the syringe (40) comprises a syringe outlet (44), and wherein the device (1) comprises a flow path from the enzyme reservoir (10) via the first purification compartment (20) to the syringe inlet (43). Also provided herein are methods for preparing a cell suspension.Type: ApplicationFiled: December 1, 2021Publication date: January 25, 2024Applicant: CUTISS AGInventors: Vincent RONFARD, Joaquin URDINEZ, Claude HOLENSTEIN
-
Publication number: 20230167498Abstract: The invention relates to methods of determining the phenotype of hair follicles. More specifically, the invention relates to a new method of determining the phenotype of a hair follicle by determining the expression profile of the cellular material attached to a plucked hair.Type: ApplicationFiled: April 16, 2021Publication date: June 1, 2023Applicant: HairClone LimitedInventors: Paul KEMP, Jennifer DILLON, Vincent RONFARD
-
Publication number: 20230114908Abstract: The invention relates to a fully disposable system for casting, polymerizing and compressing a hydrogel. The invention further relates to a method for producing a scaffold for the generation of artificial tissue products using said disposable system.Type: ApplicationFiled: March 1, 2021Publication date: April 13, 2023Inventors: Claude Nicolas HOLENSTEIN, Jerry DONNAN, Vincent RONFARD
-
Publication number: 20230101666Abstract: The present invention relates to a device and method for automatically isolating viable cells from connective, epithelial or other tissue, and, if the tissue is multilayered, for automatically separating one tissue layer from another.Type: ApplicationFiled: February 5, 2021Publication date: March 30, 2023Inventors: Claude Nicolas HOLENSTEIN, Vincent RONFARD, Anna-Lena DITTRICH, Reto FREI, Christian Stefan WULLSCHLEGER, Jascha EISENBERG, Sebastian WOLLMANN
-
Publication number: 20230000513Abstract: The present invention relates to a method for producing skin grafts for rehabilitation of skin defects, where the method is carried out in a closed system operated and controlled in an automated manner.Type: ApplicationFiled: November 22, 2020Publication date: January 5, 2023Inventors: Vincent RONFARD, Claude HOLENSTEIN, Anna-Lena DITTRICH, Laurent BARNES, Reto FREI, Ulrich ÖFFINGER, Boris STOLZ
-
Publication number: 20220225969Abstract: The present invention relates to a device adapted to facilitate transport of a biopsy sample from a sterile extraction site to laboratory-type equipment by which the biopsy sample is processed, while maintaining the biopsy sample wetted and sterile and automatically transferring the biopsy sample from the device to the laboratory-type equipment.Type: ApplicationFiled: June 3, 2020Publication date: July 21, 2022Inventors: Astrid Welti, Claude Holenstein, Vincent Ronfard, Anna-Lena Dittrich, Reto Frei, Christian Wullschleger, Sebastian Wollmann
-
Publication number: 20210379115Abstract: The invention in relates in part to a method for rejuvenating hair follicles, the method comprising the steps of: (1) obtaining androgen non-inhibited cells from hair follicle tissue; (2) culturing the androgen non-inhibited cells to produce an expanded population of androgen-non-inhibited cells; and (3) implanting the expanded population of androgen non-inhibited cells proximal to miniaturised and/or miniaturising hair follicles.Type: ApplicationFiled: October 17, 2019Publication date: December 9, 2021Inventors: Paul KEMP, Vincent RONFARD
-
Publication number: 20170360904Abstract: Provided are methods for repairing a wound or inducing the proliferative phase of a wound comprising administering a composition comprising a protease mixture comprising collagenases and a neutral protease to the wound in an amount effective for repair of wound tissue or for inducing the proliferative phase in the wound.Type: ApplicationFiled: December 10, 2015Publication date: December 21, 2017Applicant: SMITH & NEPHEW, INC.Inventors: Ira HERMAN, Vincent RONFARD, Lei SHI
-
Patent number: 7824913Abstract: Cultured tissue constructs comprising cultured cells and endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. Some tissue constructs of the invention are comprised of multiple cell layers or more than one cell type. The tissue constructs of the invention have morphological features and functions similar to tissues their cells are derived and their strength makes them easily handleable. Preferred cultured tissue constructs of the invention are prepared in defined media, that is, without the addition of chemically undefined components.Type: GrantFiled: March 13, 2000Date of Patent: November 2, 2010Assignee: Organogenesis, Inc.Inventors: Michael P. Murphy, Vincent Ronfard
-
Publication number: 20080108134Abstract: Cultured tissue constructs comprising cultured cells and endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. Some tissue constructs of the invention are comprised of multiple cell layers or more than one cell type. The tissue constructs of the invention have morphological features and functions similar to tissues their cells are derived and their strength makes them easily handleable. Preferred cultured tissue constructs of the invention are prepared in defined media, that is, without the addition of chemically undefined components.Type: ApplicationFiled: October 31, 2007Publication date: May 8, 2008Applicant: Organogenesis, Inc.Inventors: Michael Murphy, Vincent Ronfard
-
Publication number: 20080009064Abstract: The invention relates to compositions and methods useful for cell culture in which cell adherence and release of cultured cells can be performed in a temperature-responsive manner.Type: ApplicationFiled: July 6, 2007Publication date: January 10, 2008Inventors: Vincent Ronfard, Christopher O'Reilly
-
Publication number: 20070243158Abstract: The invention is directed to compositions containing growth agents synthesized from cultured cells from skin. Skin cells such as keratinocytes and dermal fibroblasts are cultured in vitro in cell medium and in the course of culture the cultured cells synthesize and secrete agents into the cell medium. The medium containing agents are collected and incorporated into pharmaceutical or cosmetic preparations to treat an individual. The preparation is applied and has a rejuvenating effect on the cells and tissue.Type: ApplicationFiled: June 12, 2007Publication date: October 18, 2007Applicant: ORGANOGENESIS, INC.Inventors: Vincent Ronfard, Alan Tuck, Leon Wilkins
-
Publication number: 20060240555Abstract: The present invention relates to fibrin cell supports for cell cultures formed by the mixture of plasma proteins including fibrinogen and thrombin. The fibrin cell supports are preferably used for preparing a culture of cells such as keratinocytes, recovering the culture in the form of a reconstituted tissue, and transporting same. The reconstituted tissue is particularly suitable for use as a skin graft.Type: ApplicationFiled: February 24, 2006Publication date: October 26, 2006Applicant: DFB Pharmaceuticals, Inc.Inventor: Vincent Ronfard
-
Publication number: 20060134093Abstract: The present invention relates to fibrin cell supports for cell cultures formed by the mixture of plasma proteins including fibrinogen and thrombin. The fibrin cell supports are preferably used for preparing a culture of cells such as keratinocytes, recovering the culture in the form of a reconstituted tissue, and transporting same. The reconstituted tissue is particularly suitable for use as a skin graft.Type: ApplicationFiled: September 5, 2003Publication date: June 22, 2006Applicant: DFB Pharmaceuticals, Inc.Inventor: Vincent Ronfard
-
Publication number: 20040126881Abstract: The present invention relates to fibrin cell supports for cell cultures formed by the mixture of plasma proteins including fibrinogen and thrombin. The fibrin cell supports are preferably used for preparing a culture of cells such as keratinocytes, recovering the culture in the form of a reconstituted tissue, and transporting same. The reconstituted tissue is particularly suitable for use as a skin graft.Type: ApplicationFiled: September 4, 2003Publication date: July 1, 2004Inventor: Vincent Ronfard
-
Patent number: 6673603Abstract: The present invention provides the use and composition of matter of angiogenic or other growth factors expressed by combining various types and stages of differentiation of allogeneic human cell strains or lines in unencapsulated pastes (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) to be temporarily applied to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.Type: GrantFiled: August 30, 2001Date of Patent: January 6, 2004Assignee: Modex Therapeutiques, S.A.Inventors: E. Edward Baetge, Thomas Hunziker, Alain Limat, Vincent Ronfard
-
Publication number: 20020172705Abstract: Cultured tissue constructs comprising cultured cells and endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. Some tissue constructs of the invention are comprised of multiple cell layers or more than one cell type. The tissue constructs of the invention have morphological features and functions similar to tissues their cells are derived and their strength makes them easily handleable. Preferred cultured tissue constructs of the invention are prepared in defined media, that is, without the addition of chemically undefined components.Type: ApplicationFiled: March 13, 2000Publication date: November 21, 2002Inventors: Michael P. Murphy, Vincent Ronfard
-
Publication number: 20020048563Abstract: The present invention provides the use and composition of matter of angiogenic or other growth factors expressed by combining various types and stages of differentiation of allogeneic human cell strains or lines in unencapsulated pastes (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) to be temporarily applied to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.Type: ApplicationFiled: August 30, 2001Publication date: April 25, 2002Inventors: E. Edward Baetge, Thomas Hunziker, Vincent Ronfard
-
Patent number: 5474770Abstract: The present invention relates to a biological support for cell cultures formed by the coagulated mixture of a concentrate of plasma proteins and thrombin.The protein concentrate is obtained by precipitating fresh plasma with ethanol and contains balanced proportions of fibrinogen, Factor XIII and fibronectin. The thrombin concentration is adjusted to obtain the desired consistency of the support coagulated in the form of a film.The biological support is preferably used for preparing a culture of keratinocytes, recovering them in the form of a reconstituted tissue and transporting same. The reconstituted tissue is thus particularly suitable for use as a graft.Type: GrantFiled: March 12, 1992Date of Patent: December 12, 1995Assignee: Centre Regional de Transfusion Sanguine de LilleInventors: Herve Broly, Vincent Ronfard